Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abelmoschus manihot versus losartan for diabetic kidney disease
ChiCTR1900025273Phase 4Completed
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in diabetic glomerulosclerosis comparing Abelmoschus manihot with Losartan potassium (2 arms). Primary endpoint: albumin-to-creatinine ratio. Started Aug 2019; status: completed.
02
Drugs
huang kui capsulelosartan
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on ChiCTR1900025273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025273.